TITLE

Heart Support

AUTHOR(S)
Stone, Andy
PUB. DATE
May 2008
SOURCE
Forbes Asia;5/5/2008, Vol. 4 Issue 8, p68
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the clinical trial of HeartMate II, a heart pump from Thoratec Corp. The company is awaiting U.S. Food & Drug Administration clearance for its use as a stopgap for patients hoping to get a heart. In 2009 the trial will be completed, which aimed at showing that the device can be implanted permanently in lieu of a transplant.
ACCESSION #
32090448

 

Related Articles

  • Decellularized heart valve gains FDA-clearance.  // Medical Technology & Devices Week;2/19/2008, Vol. 6 Issue 7, p2 

    This article reports on the 410(k) clearance given by the U.S. Food and Drug Administration to CryoLife's CryoValve SynerGraft decellularized replacement heart valve. This heart valve is used to replace diseased, damaged, malformed or malfunctioning pulmonary valves, mostly in children who face...

  • Sunshine's C-Pulse implanted in first U.S. female patients. PEDERSEN, AMANDA // Medical Device Daily;8/11/2009, Vol. 13 Issue 153, p1 

    The article reports that Sunshine Heart has implanted its C-Pulse heart assist device in two female patients in the U.S. The Tustin, California-based company was asked by the U.S. Food and Drug Administration (FDA) to use the said device in female heart failure patients. The company has...

  • Gore to start study on prevention of stroke.  // Medical Technology & Devices Week;5/12/2008, Vol. 6 Issue 19, p3 

    This article states that the U.S. Food and Drug Administration (FDA) has given W.L. Gore & Associates the approval to conduct the Gore REDUCE clinical study for its Gore Helex Septal Occluder to be applied in patient foramen ovale (PFO) closure to prevent recurrent stroke. It reveals that W.L....

  • FDA panel to review Thoratec's HeartMate II PMA in November.  // Medical Device Daily;8/16/2007, Vol. 11 Issue 156, p10 

    The article reports on the review of Thoratec's application for its HeartMate II implantable device by a Circulatory Systems Device Advisory Panel of the U.S. Food and Drug Administration on November 30, 2007. Thoratec has filed an amendment to its premarket approval application for the device....

  • With Thoratec's FDA approval…Heartmate II leads the way in options for smaller bodies. Yoffee, Lynn; Long, Don // Cardiovascular Devices & Drugs;May2008, Vol. 14 Issue 5, p4 

    The article reports that the U.S. Food & Drug Administration's (FDA) approval of the HeartMate II Left Ventricular Assist System (LVAS), an advanced generation ventricular assist device (VAD) from Thoratec is leading the way in heart pump devices that are smaller and more available for...

  • HeartMate II is approved for use in women, smaller men.  // Medical Device Daily;4/22/2008, Vol. 12 Issue 78, p1 

    The article reports that Thoratec has received approval for its Heart-Mate II Left Ventricular Assist System (LVAS) from the U.S. Food and Drug Administration (FDA) in April 2008. It is a mechanical support for small men and women who suffer from heart failure. According to Daniel Schulz,...

  • HeartMate II gets panel approval despite excess bleeding data. McCarty, Mark // Medical Device Daily;12/4/2007, Vol. 11 Issue 219, p1 

    The article reports on the approval given to HeartMate II (HMII) by the circulatory systems advisory panel of the U.S. Food and Drug Administration (FDA). The new generation of HeartMate left ventricular assist device (LVAD) made by Thoratec was given approval by the panel despite not being able...

  • Product Pipeline.  // Cardiovascular Devices & Drugs;Jun2009, Vol. 15 Issue 6, p23 

    The article reports that the U.S. Food and Drug Administration (FDA) has given approval to Edward Lifesciences for its Carpentier-Edwards Perimount Magna Ease aortic valve. It has a low profile and smooth commissure that makes it easy to be implanted in the heart via small incisions or small...

  • After PAS-Port OK by FDA, Cardica's shares jump by 35%. FORD, OMAR // Cardiovascular Devices & Drugs;Oct2008, Vol. 14 Issue 10, p22 

    The article reports on the approval of the PAS-Port Proximal Anastomosis System from Cardica by the U.S. Food and Drug Administration (FDA). The system is for use in cardiac bypass surgery in the U.S. The FDA approval resulted in more than 35 percent rise in the stock price of the company. It is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics